NeuroSave, Inc. — Form D/A
NeuroSave, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2015-06-10. The offering totals $2.5M, of which $1.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2015-06-10
- Form: D/A
- Accession: 0001551174-15-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $1.1M
- Remaining: $1.4M
- Investors: 17
- Date of first sale: 2014-05-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-219020
Issuer
- Name: NeuroSave, Inc.
- CIK: 0001551174
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 617.230.2012
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Andrew Scott | Executive Officer | LONDON, X0 |
| Thomas Kreck | Director | San Francisco, CA |
| Thomas Kreck | Executive Officer | San Francisco, CA |
| Seth Rodgers | Director | San Francisco, CA |
| Seth Rodgers | Executive Officer | San Francisco, CA |
| Andrew T Scott | Executive Officer | San Francisco, CA |
| Thomas T Kreck | Director | San Francisco, CA |
| Thomas T Kreck | Executive Officer | San Francisco, CA |
| Seth T Rodgers | Director | San Francisco, CA |
| Seth T Rodgers | Executive Officer | San Francisco, CA |
Other filings by this issuer (4)
More